Stocktoria
EDAP TMS SA FOCL
Nasdaq · stock · Electromedical & Electrotherapeutic Apparatus · website · IPO 1997-08-01
EDAP TMS SA financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $70.5M | $69.4M | $60.4M | $55.1M | $44.1M | $41.7M | $44.9M | $39.2M | $35.7M | $35.6M |
| Gross profit | $30.0M | $28.7M | $24.4M | $24.2M | $18.4M | $18.4M | $21.0M | $16.9M | $14.8M | $16.4M |
| R&D expense | $9.7M | $8.4M | $7.0M | $4.9M | $3.4M | $4.5M | $3.7M | $4.1M | $3.9M | $3.9M |
| Operating income | -$24.7M | -$22.2M | -$19.8M | -$4.3M | -$1.6M | $269,000 | $2.2M | -$1.3M | -$2.0M | $392,000 |
| Interest expense | — | — | $232,000 | $168,000 | $52,000 | $108,000 | $165,000 | $111,000 | $44,000 | $57,000 |
| Income tax | $438,000 | $313,000 | $644,000 | $837,000 | $193,000 | $516,000 | $679,000 | $358,000 | $388,000 | $602,000 |
| Net income | -$29.2M | -$20.6M | -$21.2M | -$2.9M | $699,890 | -$1.7M | $1.5M | -$338,000 | -$681,345 | $3.8M |
| EPS (diluted) | $-0.78 | $-0.55 | $-0.57 | $-0.09 | $0.02 | $-0.06 | $0.05 | $-0.01 | $-0.02 | $0.13 |
| Operating cash flow | -$16.4M | -$14.7M | -$14.7M | -$3.0M | $4.4M | $2.0M | $3.8M | $175,000 | -$3.1M | $1.2M |
| Cash & equivalents | $20.5M | $31.0M | $43.5M | $63.1M | $47.2M | $24.7M | $20.9M | $19.5M | $20.0M | $22.0M |
| Inventory | $12.8M | $19.2M | $15.1M | $11.8M | $7.5M | $8.0M | $8.2M | $7.2M | $6.7M | $8.0M |
| Total assets | $79.0M | $89.4M | $91.5M | $101.1M | $77.2M | $55.2M | $53.1M | $48.7M | $46.9M | $46.6M |
| Total liabilities | $59.6M | $46.9M | $34.6M | $29.5M | $27.2M | $28.9M | $25.7M | $23.8M | $21.7M | $22.1M |
| Shareholders' equity | $19.4M | $42.5M | $62.9M | $71.6M | $50.1M | $26.2M | $27.4M | $25.0M | $25.2M | $24.5M |
Growth · year-over-year · Revenue CAGR 7.9%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +1.6% | +14.8% | +9.6% | +25.1% | +5.8% | -7.2% | +14.6% | +9.6% | +0.4% | +10.4% |
| Net income growth | — | — | — | -519.1% | — | -212.7% | — | — | -117.7% | — |
| EPS growth | — | — | — | -550.0% | — | -220.0% | — | — | -115.4% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.